AllianceBernstein’s Immune Design Corp. IMDZ Stock Holding History

AllianceBernstein’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-11,500	Closed	-$67K	–	3270
2019 Q1	$67K	Sell	11,500 -2,500	-18%	-$8.52K	﹤0.01%	3067
2018 Q4	$18K	Sell	14,000 -2,200	-14%	-$3.82K	﹤0.01%	3087
2018 Q3	$56K	Hold	16,200	–	–	﹤0.01%	3110
2018 Q2	$74K	Buy	16,200 +4,400	+37%	+$17.5K	﹤0.01%	3077
2018 Q1	$39K	Hold	11,800	–	–	﹤0.01%	3002
2017 Q4	$46K	Sell	11,800 -300	-2%	-$1.63K	﹤0.01%	3000
2017 Q3	$125K	Hold	12,100	–	–	﹤0.01%	3020
2017 Q2	$118K	Buy	+12,100	New	+$84.9K	﹤0.01%	3084
2015 Q2	–	Sell	-1,400	Closed	-$30K	–	3566
2015 Q1	$30K	Buy	+1,400	New	+$36.5K	﹤0.01%	3207

AllianceBernstein's IMDZ Position: Q2 2019 in Review

AllianceBernstein sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 11,500 shares — an estimated $67K sold.

AllianceBernstein first reported a position in IMDZ in Q1 2015 and held it in 9 quarters. The position peaked at $125K in Q3 2017. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

AllianceBernstein reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
AllianceBernstein sold 11,500 Immune Design Corp. shares in Q2 2019, an estimated $67K.
AllianceBernstein first reported a position in Immune Design Corp. in Q1 2015 and held it in 9 quarters.
AllianceBernstein's Immune Design Corp. position peaked at $125K in Q3 2017.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on AllianceBernstein's 13F filing for Q2 2019, filed 14 Aug 2019.